In triple-negative breast cancer, the tumor suppressor miR-34a suppresses the expression of IL-6R and attenuates the role of the MCT-1 gene in epithelial-mesenchymal transition (EMT). This evidence concerns the gene IL6R and triple-negative breast carcinoma.